According to a new report North America Biodefense Market, published by KBV research, the North America Biodefense Market would witness market growth of 5% CAGR during the forecast period (2020-2026).
The US market dominated the North America Biodefense Market by Country in 2019, growing at a CAGR of 4.3 % during the forecast period. The Canada market is exhibiting a CAGR of 7.4% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 6.5% during (2020 - 2026).
The Anthrax market dominated the Canada Biodefense Market by Product in 2019, growing at a CAGR of 6.2 % during the forecast period. The Smallpox market is experiencing a CAGR of 6.5% during (2020 - 2026). Additionally, The Botulism market would showcase highest CAGR of 9.1% during (2020 - 2026).
Full Report: https://www.kbvresearch.com/north-america-biodefense-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Xoma Corporation, Altimmune, Inc., Emergent BioSolutions, Inc., Dynavax Technologies Corporation, SIGA Technologies, Inc., Elusys Therapeutics, Inc., Ichor Holdings, Ltd., Cleveland BioLabs, Inc., Bavarian Nordic A/S and Alnylam Pharmaceuticals, Inc.
By Product
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
